请使用支持JavaScript的浏览器! Adipogen/WY-14643/AG-CR1-3566-M250/250 mg-蚂蚁淘商城
新闻动态

Adipogen/WY-14643/AG-CR1-3566-M250/250 mg

  
  2024-04-28
  
More Information Product Details Synonyms Product Type Properties Formula MW CAS RTECS Purity Chemicals Appearance Solubility InChi Key Shipping and Handling Shipping Short Term Storage Long Term Storage Use/Stability Documents MSDS Product Specification Sheet Datasheet
Pirinixic acid; NSC 310038; BRN 0759945; ((4-Chloro-6-((2,3-dimethylphenyl)amino)-2-pyrimidinyl)thio) acetic acid
Chemical
C14H14ClN3O2S
323.8
50892-23-4
AG2915000
≥98%
Off-white solid.
Soluble in ethanol, DMSO, dimethyl formamide or PBS (pH 7.2).
NSHPHXHGRHSMIK-WAXGXQFOSA-N
AMBIENT
+4°C
-20°C
Stable for at least 2 years after receipt when stored at -20°C.
Download PDF
Download PDF
  • Potent peroxisome proliferator-activated receptor (PPARα) activator [1, 2, 7, 9]. Activates also PPARγ [4, 7] but not PPARδ [8].
  • Potent anti-hypercholesterolemic agent [1].
  • Hypolipidemic compound. Lipogenesis inducer [2, 10].
  • Tumor promoter [2, 3, 5, 15].
  • Causes increased cell proliferation and decreased apoptosis [5].
  • Anti-inflammatory. Inhibits NF-κB transcriptional activity and decreases the inflammatory response by reducing the production of inflammatory cytokines (TNF-α, IL1β). Reduces oxidative stress [6, 7, 12, 13].
  • Increases fatty acid oxidation [11].
  • Directly affects insulin signaling. Increases glucose uptake [12].
  • Reviews [5, 11, 14].
Product References
  • A potent antihypercholesterolemic agent: (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio) acetic acid (Wy-14643): A.A. Santilli, et al.; Experientia 30, 1110 (1974)
  • The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes: D.E. Moody & J.K. Reddy; Am. J. Pathol. 90, 435 (1978)
  • Peroxisome proliferation and hepatocarcinogenesis: M.S. Rao & J.K. Reddy; Carcinogenesis8, 631 (1987)
  • Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids:A. Schmidt,et al.; Mol. Endocrinol.6,1634 (1992)
  • Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators: R.A. Roberts; Ann. N. Y. Acad. Sci. 804, 588 (1996) (Review)
  • The PPARα-leukotriene B4 pathway to inflammation control: P.R. Devchand,et al.; Nature384,39(1996)
  • Peroxisome proliferator-activated receptors a and g are activated by indomethacin and other non-steroidal anti-inflammatory drugs: J.M. Lehmann, et al.;J. Biol. Chem.272,3406 (1997)
  • Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta: B.M. Forman, et al.; PNAS 94, 4312 (1997)
  • Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators: B. Staels, et al.; Nature393,790(1998)
  • Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48: D. Lindén, et al.; J. Biol. Chem. 277, 23044 (2002)
  • Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart: B.N. Finck & D.P. Kelly; J. Mol. Cell Cardiol. 34, 1249 (2002) (Review)
  • WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients: K. Bouzakri, et al.; Diabetologia 47, 1314 (2004)
  • Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643: M. Collino, et al.; Free Radic. Biol. Med. 41, 579 (2006)
  • Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643: P. Zahradka; Cardiovasc. Drug Rev. 25, 99 (2007) (Review)
  • PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators; F.J. Gonzalez & Y.M. Shah; Toxicology 246, 2 (2008)
  • 本文链接: https://www.ebiomall.com/b285-adi/info-1452787092.html

    免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
    版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
    没有了
    品牌问答

    暂无品牌问答